Abstract
Therapeutic drug monitoring (TDM) combines the quantification of drug concentrations in blood, pharmacological interpretation and treatment guidance. TDM introduces a precision medicine tool in times of increasing awareness of the need for personalized treatment. In neurology and psychiatry, TDM can guide pharmacotherapy for patient subgroups such as children, adolescents, pregnant women, elderly patients, patients with intellectual disabilities, patients with substance use disorders, individuals with pharmacokinetic peculiarities and forensic patients. Clear indications for TDM include lack of clinical response in the therapeutic dose range, assessment of drug adherence, tolerability issues and drug-drug interactions. Based upon existing literature, recommended therapeutic reference ranges, laboratory alert levels, and levels of recommendation to use TDM for dosage optimization without specific indications, conversion factors, factors for calculation of dose-related drug concentrations and metabolite-to-parent ratios were calculated. This summary of the updated consensus guidelines by the TDM task force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie offers the practical and theoretical knowledg...Continue Reading
References
Feb 1, 1985·The American Journal of Psychiatry
May 1, 1971·Lancet·D E Fry, V Marks
Nov 20, 2004·Pharmacopsychiatry·P BaumannUNKNOWN Arbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie
Dec 27, 2005·Epilepsy Research·Charles E Pippenger
Jul 28, 2006·Pharmacopsychiatry·M HendsetE Molden
Sep 2, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Eveline Jaquenoud SirotPierre Baumann
Aug 13, 2008·Analytical and Bioanalytical Chemistry·Ulrich M ZangerMatthias Schwab
Nov 11, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jose de Leon
May 28, 2010·The British Journal of Psychiatry. Supplement·David Taylor
Oct 5, 2011·Pharmacopsychiatry·C HiemkeG Zernig
May 9, 2012·Molecular Psychiatry·J C StinglR Viviani
Jan 25, 2013·Current Clinical Pharmacology·Stefano Spanarello, Teresa La Ferla
Jul 31, 2013·Schizophrenia Research·Suresh MallikaarjunW Wolfgang Fleischhacker
Mar 13, 2014·Der Nervenarzt·E Haen
Jun 14, 2014·The British Journal of Psychiatry : the Journal of Mental Science·W Wolfgang FleischhackerJohn M Kane
Apr 18, 2015·British Journal of Clinical Pharmacology·Jose de Leon
May 6, 2015·Journal of Neural Transmission·Gudrun HefnerChristoph Hiemke
Oct 4, 2016·European Archives of Psychiatry and Clinical Neuroscience·Michael PaulzenGeorgios Schoretsanitis
Nov 5, 2016·Journal of Clinical Psychopharmacology·Georgios SchoretsanitisMichael Paulzen
Sep 15, 2017·Pharmacopsychiatry·C HiemkeP Baumann
Sep 20, 2017·Pharmacopsychiatry·Gerhard Gründer
Citations
Jul 31, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Dario CattaneoCristina Gervasoni
Nov 20, 2018·Expert Review of Clinical Pharmacology·Georgios SchoretsanitisJose de Leon
Nov 6, 2018·Drug Metabolism and Personalized Therapy·Ana E Rodríguez VicenteAna M Peiró
Feb 26, 2019·Clinical Pharmacology and Therapeutics·Jacob T BrownJ Steven Leeder
May 11, 2019·Expert Review of Clinical Pharmacology·Georgios SchoretsanitisJose de Leon
May 17, 2019·International Clinical Psychopharmacology·Christoph KowalewskiGeorgios Schoretsanitis
Dec 2, 2019·European Journal of Clinical Pharmacology·Michel ArvidssonStaffan Rosenborg
Dec 10, 2019·Basic & Clinical Pharmacology & Toxicology·Pierre BaumannMarkus Gastpar
Sep 1, 2019·Current Pharmaceutical Biotechnology·Houli LiWeiyi Feng
Mar 3, 2020·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Jose de LeonCan-Jun Ruan
Mar 7, 2020·Journal of Clinical Psychopharmacology·Domenico De DonatisAlois Saria
Apr 3, 2020·Expert Opinion on Drug Metabolism & Toxicology·Georgios SchoretsanitisAndreas A Westin
Apr 21, 2020·Basic & Clinical Pharmacology & Toxicology·Maxim KuzinMichael Paulzen
Jun 2, 2020·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Rainer Rupprecht
Mar 21, 2020·Frontiers in Pharmacology·Thierry BuclinLaurent A Decosterd
Aug 14, 2020·Human Psychopharmacology·Daria PiacentinoAndreas Conca
Aug 7, 2019·Dose-response : a Publication of International Hormesis Society·Hugo Juárez Olguín
Jun 18, 2019·Journal of Clinical Psychopharmacology·Jaqueline BarclayJose de Leon
Nov 30, 2019·CNS Drugs·Georgios SchoretsanitisMichael Paulzen
Jul 19, 2020·NPJ Schizophrenia·Lennart KyllesøEspen Molden
Jan 7, 2020·Mass Spectrometry Reviews·Jia-Jia CuiJi-Ye Yin
Jun 1, 2019·Neuropharmacology·Jose de Leon
Feb 16, 2021·Journal of Clinical Psychopharmacology·Domenico De DonatisLaura Mercolini
Aug 24, 2020·The Lancet. Psychiatry·Jose M RubioJohn M Kane
May 8, 2021·Journal of Clinical Pharmacy and Therapeutics·Yumiko AkamineMasatomo Miura
Jun 3, 2021·International Journal of Molecular Sciences·Kouji Fukuyama, Motohiro Okada
Jun 3, 2021·Pharmaceuticals·Nicole MoschnyCatharina Meissner
Jun 8, 2021·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Domenico De DonatisVincenzo Florio
Jun 29, 2021·International Journal of Psychiatry in Medicine·Ian R McGraneMichael D Shuman
Jun 30, 2021·Journal of Clinical Pharmacology·Praneeth JarugulaJogarao V S Gobburu
Aug 5, 2021·Pharmacogenomics·Jose de Leon
Aug 22, 2021·CNS Drugs·Lennart KyllesøEspen Molden
Jun 4, 2019·La Presse médicale·Florian FerreriStéphane Mouchabac